Astrazeneca Up Nearly 6%, on Pace for Largest Percent Increase Since November 2022 -- Data Talk
Astrazeneca PLC Sponsored ADR (AZN) is currently at $75.28, up $4.08 or 5.74% --Would be highest close since May 16, 2023, when it closed at $75.28 --On pace for largest percent increase since Nov.
Jefferies Sticks to Its Buy Rating for Sanofi (SNYNF)
Bristol-Myers Squibb Down Over 6%, On Track for Largest Percent Decrease Since March 2020 -- Data Talk
Bristol-Myers Squibb Company (BMY) is currently at $45.58, down $3.28 or 6.71% --Would be lowest close since Aug. 5, 2019, when it closed at $45.38 --On pace for largest percent decrease since March
Trending: Bristol Myers Squibb Cuts '24 EPS Outlook, Plans Job Cuts in Cost Saving Efforts
10:19 ET--Bristol Myers Squibb is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The drugmaker reported a first-quarter loss of
Research Alert: CFRA Retains Buy View On Shares Of Merck & Co., Inc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target to $146 from $137, 1
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones falling over 600 points on Thursday.Shares of Sanofi SA (NASDAQ:SNY) rose sharply during Thursday's session following better-than-expected first-quarter earn